Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) COO Sells 5,000 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) COO Ryan Fukushima sold 5,000 shares of the business's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $60.00, for a total value of $300,000.00. Following the sale, the chief operating officer owned 145,000 shares of the company's stock, valued at approximately $8,700,000. The trade was a 3.33% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Ryan Fukushima also recently made the following trade(s):

• On Tuesday, May 20th, Ryan Fukushima sold 7,820 shares of Tempus AI stock. The shares were sold at an average price of $63.21, for a total value of $494,302.20.
• On Tuesday, May 6th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $52.36, for a total value of $1,047,200.00.

Tempus AI Stock Up 1.8%

Shares of TEM traded up $1.02 during trading hours on Thursday, reaching $59.43. The company's stock had a trading volume of 2,813,646 shares, compared to its average volume of 7,448,565. The firm has a market cap of $10.29 billion and a price-to-earnings ratio of -7.63. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The company has a 50 day moving average of $62.83 and a two-hundred day moving average of $54.48.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The company's quarterly revenue was up 75.4% compared to the same quarter last year. As a group, research analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on TEM shares. Morgan Stanley upped their price objective on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Bank of America raised their target price on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Guggenheim raised their target price on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. BTIG Research began coverage on shares of Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 price target on the stock. Finally, Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Wednesday, May 7th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Tempus AI currently has a consensus rating of "Moderate Buy" and a consensus price target of $65.09.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Victory Capital Management Inc. acquired a new position in shares of Tempus AI during the 4th quarter worth about $216,000. Wells Fargo & Company MN raised its stake in shares of Tempus AI by 13.2% during the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after purchasing an additional 278 shares in the last quarter. SeaCrest Wealth Management LLC acquired a new position in shares of Tempus AI during the 1st quarter worth approximately $535,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after acquiring an additional 1,016,384 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. acquired a new position in Tempus AI in the 1st quarter valued at $1,019,000. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.